Bladder cancer incidence and mortality in patients treated with radiation for uterine cancer

BJU International

Volumn 114, Issue 6, 2014, Pages 844-851

  Baack Kukreja, Janet E ^a   Scosyrev, Emil ^a   Brasacchio, Ralph A ^a   Toy, Eugene P ^a   Messing, Edward M ^a   Wu, Guan ^a  

^a STRONG MEMORIAL HOSPITAL   (United States)

Author keywords

bladder cancer; disease specific mortality; epidemiology and end results database); radiation therapy; second primary malignancy; SEER (surveillance; uterine cancer

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER GRADING; CANCER INCIDENCE; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER STAGING; CLINICAL EVALUATION; COHORT ANALYSIS; DISEASE ASSOCIATION; EXTERNAL BEAM RADIOTHERAPY; FATALITY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MUSCLE INVASIVE BLADDER CANCER; RADIATION INJURY; RETROSPECTIVE STUDY; TREATMENT OUTCOME; TUMOR INVASION; UTERUS CANCER; ADVERSE EFFECTS; INCIDENCE; MIDDLE AGED; MORTALITY; NEOPLASMS, SECOND PRIMARY; PATHOLOGY; RADIOTHERAPY; URINARY BLADDER NEOPLASMS; UTERINE NEOPLASMS;

AGED; FEMALE; HUMANS; INCIDENCE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; NEOPLASMS, SECOND PRIMARY; RADIOTHERAPY; RETROSPECTIVE STUDIES; URINARY BLADDER NEOPLASMS; UTERINE NEOPLASMS;

EID: 84911095377     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/bju.12543     Document Type: Article

References (20)

1. Siegel R, Naishadham D, Jemal A,. Cancer statistics, 2013. CA Cancer J Clin 2013; 63: 11-30
2. Brenner DJ, Curtis RE, Hall EJ, Ron E,. Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery. Cancer 2000; 88: 398-406
3. Brown AP, Neeley ES, Werner T, Soisson AP, Burt RW, Gaffney DK,. A population-based study of subsequent primary malignancies after endometrial cancer: genetic, environmental, and treatment-related associations. Int J Radiat Oncol Biol Phys 2010; 78: 127-135
4. Lonn S, Gilbert ES, Ron E, Smith SA, Stovall M, Curtis RE,. Comparison of second cancer risks from brachytherapy and external beam radiation therapy after uterine corpus cancer. Cancer Epidemiol Biomarkers Prev 2010; 19: 464-474
5. Kumar S, Shah JP, Bryant CS, et al. Second neoplasms in survivors of endometrial cancer: impact of radiation therapy. Gynecol Oncol 2009; 113: 233-239
6. National Cancer Institute. PDQ® Endometrial Cancer Treatment. Bethesda, MD: National Cancer Institute, Last modified 6/22/2012. Available at: http://cancer.gov/cancertopics/pdq/treatment/endometrial/HealthProfessional. Accessed June 2012
7. American College of Obstetricians and Gynecologists. ACOG practice bulletin no. 65: clinical management guidelines for obstetricians and gynecologists, August 2005: management of endometrial cancer. Obstet Gynecol 2005; 106: 413-425
8. Chaturvedi AK, Engels EA, Gilbert ES, et al. Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term risk. J Natl Cancer Inst 2007; 99: 1634-1643
9. Boice JD Jr, Day NE, Andersen A, et al. Second cancers following radiation treatment for cervical cancer. An international collaboration among cancer registries. J Natl Cancer Inst 1985; 74: 955-975
10. Roeske JC, Lujan A, Rotmensch J, Waggoner SE, Yamada D, Mundt AJ,. Intensity-modulated whole pelvic radiation therapy in patients with gynecologic malignancies. J Radiat Oncol Biol Phys 2000; 48: 1613-1621
11. Scosyrev E, Noyes K, Feng C, Messing E,. Sex and racial differences in bladder cancer presentation and mortality in the US. Cancer 2009; 115: 68-74
12. Scosyrev E, Golijanin D, Wu G, Messing EM,. The burden of bladder cancer in men and women: analysis of the years of life lost. BJU Int 2012; 109: 57-62
13. Rothman KJ, Greenland S, Lash TL,. Modern Epidemiology, 3rd edn. Philadelphia, PA: LWW, 2008: 265-268
14. National Cancer Institute. SEER Stat Software. Available at: http://seer.cancer.gov/seerstat. Accessed November 2011
15. McMeekin DS, Benedet JL, Broaddus R, et al. Corpus uteri. In, Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, eds, AJCC Cancer Staging Manual, 7th edn. New York: Springer, 2010: 403-418
16. Chang S, McKiernan JM, Amin M, et al. Urinary bladder. In, Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, eds, AJCC Cancer Staging Manual, 7th edn. New York: Springer, 2010: 497-505
17. Tilki D, Svatek RS, Karakiewicz PI, et al. Characteristics and outcomes of patients with pT4 urothelial carcinoma at radical cystectomy: a retrospective international study of 583 patients. J Urol 2010; 183: 87-93
18. Johnson EK, Daignault S, Zhang Y, Lee CT,. Patterns of hematuria referral to urologists: does gender disparity exist? Urology 2008; 72: 498-502
19. Salani R, Backes F, Fung MF, et al. Post-treatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: society of gynecologic oncologists recommendations. Am J Obstet Gynecol 2011; 204: 466-478
20. Kwon JS, Elit L, Saskin R, Hodgson D, Grunfeld E,. Secondary cancer prevention during follow-up for endometrial cancer. Obstet Gynecol 2009; 113: 790-795